Vita Therapeutics and Westwood & Wilshire Team to Bring on SVP of Pre-Clinical

Baltimore, Maryland, December 1, 2021-- Vita Therapeutics, a cell engineering company aiming to develop life-transformative treatments, has brought on Amy Wesa, PhD, as the SVP of Preclinical Sciences. Vita was founded out of Johns Hopkins University in 2019 and utilizes induced pluripotent stem cell (iPSC) technology to engineer specific cell types, designed to replace defective ones in patients.

Dr. Wesa brings over 20 years of translational cell and gene therapy experience to the role. She joins Vita from her position as Vice President of Research and Development at Champions Oncology, where she spent three years in roles of ascending responsibility. Prior to Champions, Dr. Wesa served as the Associate Director of Immuno-Oncology at Intrexon and Director of R&D at Celsense. Before joining the industry, Dr. Wesa was an Assistant Professor of Dermatology and Immunology at The University of Pittsburgh School of Medicine. She received her PhD in Cancer Biology at Wayne University School of Medicine.

This search was successfully led by James Reynolds for Westwood and Wilshire’s Life Sciences Practice.

About Westwood & Wilshire

Westwood & Wilshire is a retained executive search firm that recognizes people as any organization’s top asset. The firm has delivered premier talent to many of the world’s most innovative companies in life sciences, healthcare, and advanced technology. Westwood & Wilshire specializes in bringing top-tier candidates at the mid-management to C-Suite level to clients ranging from VC backed start-ups to mid-sized commercial entities. The firm has offices in Los Angeles, Silicon Valley, Scottsdale, and Connecticut serving clients worldwide.